A detailed history of Pine Haven Investment Counsel, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pine Haven Investment Counsel, Inc holds 4,361 shares of BMY stock, worth $256,732. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,361
Holding current value
$256,732
% of portfolio
0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$39.66 - $51.75 $172,957 - $225,681
4,361 New
4,361 $225,000
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $2,399 - $2,720
-50 Reduced 0.99%
5,026 $272,000
Q2 2023

Aug 02, 2023

SELL
$63.71 - $70.74 $13,060 - $14,501
-205 Reduced 3.88%
5,076 $324,000
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $5,913 - $6,707
-90 Reduced 1.68%
5,281 $366,000
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $288,046 - $335,794
5,371 New
5,371 $335,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pine Haven Investment Counsel, Inc Portfolio

Follow Pine Haven Investment Counsel, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Haven Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pine Haven Investment Counsel, Inc with notifications on news.